TY - JOUR
T1 - Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection
AU - Begg, Norman T.
AU - Miller, Elizabeth
AU - Fairley, Christopher K.
AU - Chapel, Helen M.
AU - Griffiths, Helen
AU - Waight, Pauline A.
AU - Ashworth, L. A.Edward
PY - 1995/1/1
Y1 - 1995/1/1
N2 - The safety and immunogenicity of two conjugate Haemophilus influenzae type B (Hib) vaccines administered either mixed with, or in separate limbs to, a whole-cell DTP vaccine, was compared in infants vaccinated at 2, 3 and 4 months of age. Antibody titres to purified polyribosylribitol phosphate, diphtheria, and to pertussis antigens between infants who received the Hib and DPT vaccines in separate limbs or in the same limbs were similar (P>0.1) while antibody titres to tetanus toxoid were higher in the later group (P<0.05). This study demonstrated that both Hib vaccines can be mixed with whole-cell DTP vaccine without reducing immunogenicity of either vaccine or increasing the incidence of adverse reactions.
AB - The safety and immunogenicity of two conjugate Haemophilus influenzae type B (Hib) vaccines administered either mixed with, or in separate limbs to, a whole-cell DTP vaccine, was compared in infants vaccinated at 2, 3 and 4 months of age. Antibody titres to purified polyribosylribitol phosphate, diphtheria, and to pertussis antigens between infants who received the Hib and DPT vaccines in separate limbs or in the same limbs were similar (P>0.1) while antibody titres to tetanus toxoid were higher in the later group (P<0.05). This study demonstrated that both Hib vaccines can be mixed with whole-cell DTP vaccine without reducing immunogenicity of either vaccine or increasing the incidence of adverse reactions.
KW - Haemophilus influenzae conjugate vaccine
UR - http://www.scopus.com/inward/record.url?scp=0028879984&partnerID=8YFLogxK
U2 - 10.1016/0264-410X(95)00091-E
DO - 10.1016/0264-410X(95)00091-E
M3 - Article
C2 - 8578840
AN - SCOPUS:0028879984
SN - 0264-410X
VL - 13
SP - 1547
EP - 1550
JO - Vaccine
JF - Vaccine
IS - 16
ER -